These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
195 related items for PubMed ID: 23001305
1. Speciation of Gd-based MRI contrast agents and potential products of transmetalation with iron ions or parenteral iron supplements. Telgmann L, Wehe CA, Künnemeyer J, Bülter AC, Sperling M, Karst U. Anal Bioanal Chem; 2012 Nov; 404(8):2133-41. PubMed ID: 23001305 [Abstract] [Full Text] [Related]
2. Analysis of the contrast agent Magnevist and its transmetalation products in blood plasma by capillary electrophoresis/electrospray ionization time-of-flight mass spectrometry. Künnemeyer J, Terborg L, Nowak S, Telgmann L, Tokmak F, Krämer BK, Günsel A, Wiesmüller GA, Waldeck J, Bremer C, Karst U. Anal Chem; 2009 May 01; 81(9):3600-7. PubMed ID: 19338293 [Abstract] [Full Text] [Related]
3. Dissociation kinetics of open-chain and macrocyclic gadolinium(III)-aminopolycarboxylate complexes related to magnetic resonance imaging: catalytic effect of endogenous ligands. Baranyai Z, Pálinkás Z, Uggeri F, Maiocchi A, Aime S, Brücher E. Chemistry; 2012 Dec 14; 18(51):16426-35. PubMed ID: 23139193 [Abstract] [Full Text] [Related]
4. Identification and quantification of potential metabolites of Gd-based contrast agents by electrochemistry/separations/mass spectrometry. Telgmann L, Faber H, Jahn S, Melles D, Simon H, Sperling M, Karst U. J Chromatogr A; 2012 Jun 01; 1240():147-55. PubMed ID: 22525874 [Abstract] [Full Text] [Related]
5. Transmetallation of Gd-DTPA by Fe3+, Cu2+ and Zn2+ in water: batch experiments and coagulation-flocculation simulations. Rabiet M, Letouzet M, Hassanzadeh S, Simon S. Chemosphere; 2014 Jan 01; 95():639-42. PubMed ID: 24183629 [Abstract] [Full Text] [Related]
6. Kinetics of the exchange reactions between Gd(DTPA)2-, Gd(BOPTA)2-, and Gd(DTPA-BMA) complexes, used as MRI contrast agents, and the triethylenetetraamine-hexaacetate ligand. Pálinkás Z, Baranyai Z, Brücher E, Rózsa B. Inorg Chem; 2011 Apr 18; 50(8):3471-8. PubMed ID: 21405037 [Abstract] [Full Text] [Related]
7. Enhanced conjugation stability and blood circulation time of macromolecular gadolinium-DTPA contrast agent. Jenjob R, Kun N, Ghee JY, Shen Z, Wu X, Cho SK, Lee DH, Yang SG. Mater Sci Eng C Mater Biol Appl; 2016 Apr 01; 61():659-64. PubMed ID: 26838894 [Abstract] [Full Text] [Related]
8. Synthesis and evaluation of novel macrocyclic and acyclic ligands as contrast enhancement agents for magnetic resonance imaging. Chong HS, Garmestani K, Bryant LH, Milenic DE, Overstreet T, Birch N, Le T, Brady ED, Brechbiel MW. J Med Chem; 2006 Mar 23; 49(6):2055-62. PubMed ID: 16539394 [Abstract] [Full Text] [Related]
9. GdIII complexes with fast water exchange and high thermodynamic stability: potential building blocks for high-relaxivity MRI contrast agents. Laus S, Ruloff R, Tóth E, Merbach AE. Chemistry; 2003 Aug 04; 9(15):3555-66. PubMed ID: 12898682 [Abstract] [Full Text] [Related]
10. Determination of gadolinium-based MRI contrast agents in biological and environmental samples: a review. Telgmann L, Sperling M, Karst U. Anal Chim Acta; 2013 Feb 18; 764():1-16. PubMed ID: 23374209 [Abstract] [Full Text] [Related]
11. The role of equilibrium and kinetic properties in the dissociation of Gd[DTPA-bis(methylamide)] (Omniscan) at near to physiological conditions. Baranyai Z, Brücher E, Uggeri F, Maiocchi A, Tóth I, Andrási M, Gáspár A, Zékány L, Aime S. Chemistry; 2015 Mar 16; 21(12):4789-99. PubMed ID: 25678406 [Abstract] [Full Text] [Related]
12. [Complexation properties of the ligand EOB-DTPA and the kinetic stability of Gd(EOB-DTPA)]. Burai L, Brücher E, Király R, Solymosi P, Víg T. Acta Pharm Hung; 2000 Mar 16; 70(3-6):89-96. PubMed ID: 11379036 [Abstract] [Full Text] [Related]
13. Determination of the MRI contrast agent Gd-DTPA by SEC-ICP-MS. Loreti V, Bettmer J. Anal Bioanal Chem; 2004 Aug 16; 379(7-8):1050-4. PubMed ID: 15235758 [Abstract] [Full Text] [Related]
14. Surface functionalization of magnetoliposomes in view of improving iron oxide-based magnetic resonance imaging contrast agents: anchoring of gadolinium ions to a lipophilic chelate. De Cuyper M, Soenen SJ, Coenegrachts K, Beek LT. Anal Biochem; 2007 Aug 15; 367(2):266-73. PubMed ID: 17568553 [Abstract] [Full Text] [Related]
15. Targeted dual-contrast T1- and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles. Yang H, Zhuang Y, Sun Y, Dai A, Shi X, Wu D, Li F, Hu H, Yang S. Biomaterials; 2011 Jul 15; 32(20):4584-93. PubMed ID: 21458063 [Abstract] [Full Text] [Related]
16. Speciation analysis of gadolinium-based MRI contrast agents in blood plasma by hydrophilic interaction chromatography/electrospray mass spectrometry. Künnemeyer J, Terborg L, Nowak S, Scheffer A, Telgmann L, Tokmak F, Günsel A, Wiesmüller G, Reichelt S, Karst U. Anal Chem; 2008 Nov 01; 80(21):8163-70. PubMed ID: 18821778 [Abstract] [Full Text] [Related]
17. Analytical interference in serum iron determination reveals iron versus gadolinium transmetallation with linear gadolinium-based contrast agents. Fretellier N, Poteau N, Factor C, Mayer JF, Medina C, Port M, Idée JM, Corot C. Invest Radiol; 2014 Dec 01; 49(12):766-72. PubMed ID: 24943092 [Abstract] [Full Text] [Related]
18. The rates of the exchange reactions between [Gd(DTPA)]2- and the endogenous ions Cu2+ and Zn2+: a kinetic model for the prediction of the in vivo stability of [Gd(DTPA)]2-, used as a contrast agent in magnetic resonance imaging. Sarka L, Burai L, Brücher E. Chemistry; 2000 Feb 18; 6(4):719-24. PubMed ID: 10807182 [Abstract] [Full Text] [Related]
19. Sensitive quantification of gadolinium-based magnetic resonance imaging contrast agents in surface waters using hydrophilic interaction liquid chromatography and inductively coupled plasma sector field mass spectrometry. Birka M, Wehe CA, Telgmann L, Sperling M, Karst U. J Chromatogr A; 2013 Sep 20; 1308():125-31. PubMed ID: 23958698 [Abstract] [Full Text] [Related]
20. Transmetallation and gadolinium: do low iron stores prevent the development of nephrogenic systemic fibrosis in high-risk end-stage renal disease patients? Panesar M, Boateng F, Patel SS, Masood SF, Mahajan P, Patel N, Murray B. Hemodial Int; 2010 Jul 20; 14(3):289-94. PubMed ID: 20662951 [Abstract] [Full Text] [Related] Page: [Next] [New Search]